Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 18 | $2,372,016 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2024 | Sale | 12,741 | 35.65 | 454,217 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2024 | Sale | 8,200 | 34.99 | 286,918 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 04 Jan 2024 | Sale | 1,600 | 32.63 | 52,208 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2024 | Sale | 1,900 | 33.99 | 64,581 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 1,700 | 32.65 | 55,505 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 400 | 33.41 | 13,364 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 2,800 | 32.52 | 91,056 | D |
05 Jan 2024 19:58 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2024 | Sale | 3,849 | 31.83 | 122,514 | D |
06 Jan 2023 19:30 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2023 | Sale | 7,500 | 37.39 | 280,425 | D |
06 Jan 2023 19:30 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 05 Jan 2023 | Sale | 7,500 | 37.39 | 280,425 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 270 | 40.53 | 10,943 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 300 | 39.55 | 11,865 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 5,286 | 38.58 | 203,934 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 2,894 | 37.58 | 108,757 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 70 | 40.8 | 2,856 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 500 | 39.74 | 19,870 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 5,527 | 38.54 | 213,011 | D |
05 Jan 2023 19:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | O'BRIEN PATRICK | COO and General Counsel | 03 Jan 2023 | Sale | 2,653 | 37.53 | 99,567 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)